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Abstract: Simulation and computational analysis of 6-gingerol and 6-shogaol is done to evaluate their binding 
affinity against ERα. Active site prediction was done using Computed Atlas of Surface Topography of Proteins 
(CASTp) to determine the binding pocket of ERα. Molecular docking and molecular dynamics (MD) simulation 
were done to assess the binding affinity and stability of the ligand-ERα complexes formed. Results showed that 
Tamoxifen have lowest binding energy (-9.61 ± 0.39 kcal/mol) followed by 6-gingerol (-6.59 ± 0.29 kcal/mol) and 
6-shogaol (-5.70 ± 0.36 kcal/mol). Inhibition constant (Ki) range of TMX-ERα was found to be drastically lower 
than both 6GN-ERα and 6SG-ERα. Based on the difference in the binding energy range and inhibition constant, 6-
gingerol and 6-shogaol showed less potential in substituting tamoxifen for the inhibition of ERɑ. Docking 
complexes formed was supported with stability in root mean square deviation (RMSD) and total binding energy of 
the complexes. The study is concluded that 6-gingerol have high level of interactions with the ERα active site in 
terms of hydrogen bonding whereas hydrophobic interactions are observed with both 6-gingerol and 6-shogaol. 
However, both ginger bioactive compounds poses low potential as substitute in comparison with tamoxifen against 
ERα. 
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1. Introduction 
Most Asian countries are struggling with an 
increasing prevalence of breast cancer and it is 
becoming a major cause of morbidity and mortality 
amongst women [1]. Malaysian breast cancer 
patients are also struggling from getting the best of 
treatments. As reported by Abdullah et al.[1], 
Malaysian breast cancer patients have a lower 
overall 5-year survival rate as compared to those in 
developed countries in the cohort of 2000 to 2005. 
Yip et al.[16] stated an over 80% of 5-year survival 
rate for USA breast cancer patients which received 
optimal treatment. Most current treatments against 
breast cancer are mostly directed towards 
preventive strategy for early detection and 
intervention in order to increase the survival rates 
[16]. 
The use of “natural” or alternative medicines 
for treatment against breast cancer has increased 
over the last few years. Due to the adverse effects 
of the synthetic breast cancer drugs, the public have 
been more favorable to accepting drugs of natural 
sources especially from plants due to the fewer side 
effects and its abundant nature. Synthetic drugs like 
tamoxifen and raloxifine are usually associated 
with high level of toxicity and harmful adverse 
effects from its administration [3]. Furthermore, 
natural products have also shown to have high 
potential in designing a more effective drug 
compared to synthetic drugs [4].Ginger rhizome 
(Zingiberofficinale) is one of a natural plants that 
being promoted as a cancer treatment to help keep 
tumors from developing [8].The two well-known 
biologically active constituents of ginger are the 
gingerols and shogaols where many homologues of 
these compounds exist. 6-gingerol is a major 
pungent phenolic compound found in ginger which 
has been reported to exhibit antioxidant activity 
through inhibition of phospholipid peroxidation 
supported by in vitro and in vivo approach [8]. 
Shogaols are the product of dehydration reaction of 
the gingerols and is therefore present in larger 
amount in dried ginger. Moreover, ginger is widely 
used in many practices such as for making spices, 
cooking and as traditional medicine. 
The constituents of ginger may show 
promising anti-cancer properties but 
pharmacological studies on its effects against breast 
cancer are scarce. Through the exploitation of 
bioinformatics, such potential can be established 
and further examined for its application in the drug 
design against breast cancer. In this study,in-silico 
analysis of 6-gingerol and 6-shogaol against the 
human breast cancer estrogen receptor alpha (ERα) 
were conducted to verify their potential 
interactions. Findings from this study will provide 
the scope for investigating these two compounds 
interaction against ERα which can be extrapolate 
for their suitability as alternative natural formulated 
breast cancer drugs.  
 
2. Methodology 
2.1 Data collection 
The three-dimensional molecular structure of 
the bioactive compounds 6-gingerol and 6-shogaol 
were downloaded from the PubChem database 
including the structure of tamoxifen (Figure 1). The 
compound identifier (CID) and other molecular 
information are listed in Table 1. Three-
dimensional structure of the human estrogen 
receptor alpha (ID: 2IOK) was acquired from the 
Protein Data Bank (PDB) database and was 
visualized as in Figure 2. 
 
 
Fig. 1: Structural formula obtained from PubChem 
and the 3D structure of ligands molecule as viewed 
in PyMOL (carbon = green, oxygen = red, nitrogen 
= blue, polar hydrogen = grey). 
 
Table1:Molecular information of the ligands 
structures obtained from PubChem. 
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Fig. 2: Visualization of ERɑ structure and the 
key active site residues as obtained from CASTp 
server and reviewed using PyMOL (blue, green & 
red = ERɑ, green & red = CASTp predetermined 
active site residues, red = incorporated residues in 
AutoDock grid map). 
 
2.2 Binding pocket prediction 
The active site residues for the ERɑ were pre-
determined prior to the docking analysis. The 
downloaded receptor structure was submitted to 
Computed Atlas of Surface Topography of Proteins 
(CASTp) online server. CASTp server enables the 
identification and measurements of the accessible 
pockets and voids on the 3D receptor structure that 
allows the visualization of the functional regions, 
surface structure and key residues of the active site 
[6, 10]. CASTp calculation (JobID: JIDSX87143Q) 
was done using the default probe radius of 1.4 Å. 
 
2.3 Molecular docking using 
autodocktools 
Molecular docking was done using 
AutoDockTools (ADT) version 1.5.6 [11]. ERɑ and 
ligands structures were loaded into the docking 
system in PDB format. Extraneous water molecules 
are removed from the protein system. The protein 
system was stabilized by adding hydrogen atoms 
and partial charges (Kollman and Gasteiger 
charges). The molecules are then exported and 
operated in PDBQT format.The binding region was 
specified within a grid map of 50 x 44 x 58 points 
with the default spacing of 0.375 Å. The grid box 
incorporates 26 of the following ERɑ residues; 
Met343, Leu346, Thr347, Leu349, Ala350, 
Asp351, Glu353, Leu354, Trp383, Leu384, 
Leu387, Met388, Leu391, Arg394, Leu402, 
Phe404, Val418, Glu419, Gly420, Met421, Ile424, 
Phe425, Leu428, Gly521, His524 and Leu525. All 
of the incorporated residues coincide with the 
determined pocket from CASTp.Molecular docking 
was proceeded using Lamarckian Genetic 
Algorithm (LGA) with an overall of 100 docking 
runs. The RMS tolerance for the docking analysis 
was set to 1.0 Å. The docking for all the studied 
compounds was done in triplicates. The structure of 
the ligand-ERɑ complexes resulted from the 
docking analysis was extracted for the molecular 
dynamics (MD) simulation. 
2.4 Molecular dynamic (MD) 
simulations 
The MD simulation was done using 
GROMACS 4.6.5 [2]. Topology files for both the 
receptor and the ligands were generated separately. 
GROMOS96 53A6 force field was used to generate 
the topology for the receptor while the topology for 
the ligands was generated using an online server, 
PRODRG [12]. 
A cubic simulation box was generated for the 
MD simulation where the protein complex was 
solvated with SPC/E water solvent. 8 Na+ ions were 
added to neutralize the negatively charged ligand-
ERɑ complex so as to produce a neutral net system 
charge. Energy minimization of the system was 
carried out to ensure no steric clashes or 
inappropriate geometry on the complex. Position 
restraint equilibration was performed on the 
complex so as to restrain particles/atoms at a fixed 
reference position. The system was equilibrated at 
constant temperature (303 K) and pressure (1 atm) 
and the MD simulation was finally operated to 
production stage of 10,000 pico-seconds (ps). 
The resulting structures from docking and MD 
simulation were viewed and analyzed using 
PyMOL[13]. PyMOL was also used to display the 
measurement of the hydrogen bond distance 
between the interacting atoms. Schematic 2D 
representation of the molecular interaction between 
the ligand and the ERɑ active site was displayed 
and examined using LigPlot+ software [15]. 
Data results from the MD simulations were 
obtained using programs available within the 
GROMACS simulation package as listed in Table 
2. An application called GRACE was used to plot 
and analyze the data. 
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Table 2:List of GROMACS programs used in result 
collection and analysis. 
 
3. Results and discussions 
3.1 Molecular docking analysis 
3.1.1 Hydrogen bond and binding 
energy 
ADT version 1.5.6 was used to predict 
predominant binding modes for the ligand-receptor 
interactions. The results from the dockings are 
ranked according to the percentage of 
conformations formed in a cluster and by its 
correlating binding energy. The conformations 
cluster of the highest rank was selected for analysis 
(Table 3). The docking simulation between the 
ligands and ERɑ resulted in three ligand-receptor 
complexes, TMX-ERɑ, 6GN-ERɑ and 6SG-ERɑ. 
Table 3:Docking simulation results based on the 
best rank of binding conformations and binding 
energy. 
Figure 3 represent the structure of TMX-ERɑ 
that shows one hydrogen bond formation between 
tamoxifen and an active site residue, Asp351. 
TMX-ERɑ has the lowest binding energy (-9.61 ± 
0.39 kcal/mol). As compared to 6GN-ERɑ (Figure 
4), two hydrogen bonds are formed from the 6-
gingerol interaction with two active site residues, 
Glu353 and Arg394. However, the binding energy 
for 6GN-ERɑ is higher (-6.59 ± 0.29 kcal/mol) 
compared to TMX-ERɑ. No hydrogen bond was 
formed from the docking of 6-shogaol and the 
binding energy was highest of all three analyzed 
compounds (-5.70 ± 0.36 kcal/mol). 
Structure of proteins and their binding with 
ligands are primarily determined by hydrogen 
bonding. As affirmed by Zhao and Huang [17], 
ligand binding is influenced by the breaking of 
hydrogen bonds with water molecules and 
formation of new hydrogen bonds between ligand 
and receptor. Conversely, the higher binding 
energy of 6GN-ERɑ compared to TMX-ERɑ 
determines a lower binding affinity to ERɑ. 
Formation of hydrogen bond that leads to 
unfavorable geometry of the ligand-receptor 
interaction could be a factor decreasing the binding 
energy. As supported by Karaman et al. [5], ligand 
binding is improved by the detachment of group 
that forms hydrogen bond in incoherent geometry. 
However, this would be inconsistent with the 
highest binding energy of 6SG-ERɑ that has no 
hydrogen bond formation. Alternatively, the 
scoring function for the binding energy has its own 
limitations. Zhao and Huang [17] stated that a 
majority of scoring functions do not include the 
enthalpic loss of hydrogen bonding in ligand 
binding interaction adequately. According to the 
binding energy of the best ranked conformations, 
the binding affinity of tamoxifen is highest 
followed by 6-gingerol and 6-shogaol respectively. 
 
Fig. 3:Molecular representation exhibits the 
formation of h-bond (yellow dash line) with 
atomic distance of 2.7 Å between tamoxifen and 
Asp351 in TMX-ERɑ (carbon = green, oxygen = 
red, nitrogen = blue). The ribbon structure 
represents the ERɑ while the line structure (red) 
represents the pocket residues. 
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Fig. 4:Molecular representation exhibits the 
formation of h-bond (yellow dash line) with 
atomic distance of 1.9 Å between 6-gingerol and 
two residues, Glu353 and Arg394 in 6GN-ERɑ 
(carbon = green, oxygen = red, nitrogen = blue). 
The ribbon structure represents the ERɑ while the 
line structure (red) represents the pocket residues. 
 
The interacting residues forming hydrogen 
bond in TMX-ERɑ is Asp351. As asserted by Liu 
et al. [9], “Amino acid Asp351 in the ligand 
binding domain of estrogen receptor alpha (ERα) 
plays an important role in regulating the estrogen-
like activity of selective estrogen receptor 
modulator-ERα complexes”. However, as 
documented by Dayan et al. [3], tamoxifen and 
most of its derivatives interact with Asp351 in an 
unfavorable mode. 
The two active site residues determined in the 
hydrogen bonding with 6-gingerol are similar to 
that of estradiol. As stated by Kumar et al. [7], 
hydroxyl groups of the natural estrogen ligand, 
estradiol formed hydrogen bond with the active 
site residues Glu353 and Arg394 of ERɑ. 
Although the interacting residues for hydrogen 
bonding between 6-gingerol and tamoxifen differ, 
6-gingerol formed stronger hydrogen bonding 
within the ERɑ pocket and thus could pose other 
ligand binding importance to the inhibition of the 
receptor. 
 
3.1.2 Inhibition constant and binding 
energy range 
As shown in Table 4, tamoxifen showed a 
binding energy range of -8.91 kcal/mol to -9.84 
kcal/mol while 6-gingerol and 6-shogaol showed 
higher binding energy range of -5.12 kcal/mol to -
7.22 kcal/mol and -5.66 kcal/mol to -7.58 kcal/mol 
respectively. The relationship between the binding 
energy is displayed in Figure 5. It is shown that 
tamoxifen have the highest binding energy level 
followed by 6-shogaol and 6-gingerol respectively. 
Another parameter tested was the inhibition 
constant (Ki) of the compounds. As shown in 
Table 5, tamoxifen showed Ki range of 65.79 nM 
to 292.25 nM while 6-gingerol and 6-shogaol 
showed Ki range of 5.09 μM to 175.26 μM and 
2.77 μM to 70.88 μM respectively. As according to 
Umamaheswari et al. [14], the inhibition constant 
is directly proportional to the binding energy. It is 
shown from the data that the decrease in inhibition 
constant of the compounds coincides with the 
decrease in the binding energy. 
 
 
Fig.5:Bar chart exhibits the relationship of binding 
energy between the compounds according to the 
docking ranks. 
 
3.2 Molecular dynamics (MD) 
simulation analysis 
3.2.1 Ligand-ERɑ complex service  
MD simulation was done to provide extensive 
data on the fluctuations and conformational 
changes of the ligand-receptor complexes. The 
atoms and molecules within the ligand-receptor 
system were allowed to interact within a timeframe 
of 10,000 ps. The parameters for determining the 
structural changes and stability of the ligand-
receptor complexes involve the assessment of the 
root mean square deviation (RMSD) and the total 
energy. 
 
3.2.2 Root mean square deviation 
Root mean square deviation (RMSD) was 
calculated to evaluate the stability of the complexes 
obtained from the docking. It determines the 
deviation in the average distance of the backbone 
structure movement in the complexes. As 
confirmed by Morris and Lim-Wilby[18], success 
in docking is generally measured in terms of 
RMSD with arbitrary threshold of 2 Å or 0.2 nm. 
As depicted in Figure 6, 6GN-ERα achieved 
stability at 2,000 ps with a standard deviation (SD) 
of ± 0.15 nm whereas the TMX-ERα achieved 
stability at 3,000 ps with SD of ± 0.15 nm. The 
6SG-ERα achieved stability at 7,000 ps with SD of 
± 0.20 nm. TMX-ERα, 6GN- ERα and 6SG-ERα 
showed minimal deviation in the RMSD which are 
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below 0.2 nm which confirms the docking structure 
stability. The results suggested that the simulation 
time established for the MD analysis was sufficient. 
 
Fig. 6: Root mean square deviation (RMSD) graph 
against time for TMX-ERɑ, 6GN-ERɑ and 6SG-
ERɑ complexes. 
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Compounds Runs 
Binding energy of compounds based on their rank (kcal/mol) 
1 2 3 4 5 6 7 8 9 10 
Tamoxifen 
1 -9.61 -9.62 -9.35 -9.27 -9.44 -8.91 -9.59 -9.33 -9.31 -9.29 
2 -9.71 -9.67 -9.61 -9.45 -9.74 -9.69 -9.35 -9.47 -9.67 -9.57 
3 -9.68 -9.71 -9.80 -9.62 -9.51 -9.73 -9.56 -9.84 -9.44 -9.46 
6-Gingerol 
1 -6.30 -6.69 -6.61 -6.58 -6.55 -6.32 -6.22 -6.17 -5.94 -5.89 
2 -6.59 -6.95 -6.79 -6.68 -6.49 -6.44 -6.08 -5.12 -7.22 -6.82 
3 -6.74 -6.72 -6.65 -6.64 -5.95 -7.01 -6.84 -6.81 -6.78 -6.74 
6-Shogaol 
1 -5.70 -7.41 -7.39 -6.79 -7.33 -7.05 -6.88 -6.79 -6.62 -6.47 
2 -6.90 -7.58 -6.81 -5.73 -7.42 -7.31 -7.53 -7.26 -7.24 -7.18 
3 -7.25 -5.66 -7.49 -6.87 -6.71 -7.54 -7.47 -7.26 -7.23 -7.09 
Table 4:Binding energy of compounds based according to docking rank (red = highest value, green = lowest value). 
Compounds Runs 
Inhibition Constant of compounds based on their rank (μM, nM*) 
1 2 3 4 5 6 7 8 9 10 
Tamoxifen 
1 89.84* 88.85* 141.18* 160.82* 119.4* 292.25* 93.07* 145.92* 150.16* 155.62* 
2 76.56* 81.05* 90.14* 118.24* 72.13* 79.30* 140.07* 114.01* 82.07* 96.26* 
3 80.84* 76.52* 65.79* 88.35* 107.64* 73.47* 97.52* 113.16* 121.14* 116.45* 
6-Gingerol 
1 24.07 12.46 14.29 15.13 15.80 23.23 27.65 29.94 44.37 47.92 
2 14.80 8.09 10.62 12.66 17.45 19.02 34.78 175.26 5.09 9.99 
3 11.42 11.83 13.43 13.68 43.15 7.28 9.70 10.12 10.69 11.44 
6-Shogaol 
1 66.17 3.71 3.80 10.62 4.21 6.76 9.0 10.47 13.98 17.95 
2 8.82 2.77 10.19 62.71 3.62 4.41 3.04 4.76 4.97 5.45 
3 4.86 70.88 3.25 9.15 12.04 2.98 3.33 4.80 5.01 6.33 
Table 5: Inhibition constant, Ki, of compounds based according to docking rank (red = highest value, green = lowest value). 
 
 
 
 
125 
Faez, S. et al., Int. J. Of Integrated Engineering:Special Issue 2018: Data Information Engineering: Vol. 10 No. 6 (2018) p. 119-127 
 
 
3.2.2 Total energy 
Total energy was taken to analyze the 
equilibrium and stability of the ligand-ERα 
complexes along the duration of the simulation. 
According to Figure 7, the total energy for all 
three complexes is seen to average within 
miniscule range. The average total energy for 
6GN-ERα is lowest (-661491 kJ/mol) followed 
by 6SG-ERα (-662214 kJ/mol) and TMX-ERα (-
662178 kJ/mol) as shown in Appendix D. 
Constant equilibrium of the total energy was 
obtained for TMX-ERα, 6GN-ERα and 6SG-ERα 
along 10,000 ps of the simulationtimeframe. 
Stability of the complexes was shown in terms of 
its total energy throughout the simulation. 
 
Fig. 7: Total energy graph against time. 
4. Conclusion 
The potential of the two bioactive 
compounds compared to the synthetic drug, 
tamoxifen was established. Results suggest that 
6-gingerol have high level of interactions with the 
ERα active site in terms of hydrogen bonding. 
However, the binding energy of both ginger 
bioactive compounds is exceptionally higher than 
tamoxifen and thus poses low potential as 
substitute. Nevertheless,6-gingerol formed strong 
hydrogen bond with Glu353 and Arg397 residues 
of the ERα. Similar residues of ERα are found to 
form hydrogen bond with estradiol. Estradiol is a 
form of estrogen that is commonly used in 
hormone replacement therapy (HRT) along with 
the administration of tamoxifen as treatment 
against ER-positive breast cancer. The use of 
estradiol remains controversial due to the high 
risk of adverse effects. According to the findings 
of this study, 6-gingerol show potential for 
further studies to determine a substitute for the 
estradiol in HRT against ER-positive breast 
cancer. Wide range of other bioactive compounds 
of ginger are also excluded in this research and 
thus can be used as an extent to this study. 
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Supplementary 
Ligand 
Compound 
PubChem 
CID 
Molecular 
Formula 
Molecular 
Weight 
(g/mol) 
H-bond 
Donor 
Count 
H-bond 
Acceptor 
Count 
Rotatable 
Bond Count 
Tamoxifen 2733526 C26H29NO 371.5145 0 2 8 
6-Gingerol 442793 C17H26O4 294.3859 2 4 10 
6-Shogaol 5281794 C17H24O3 276.3706 1 3 9 
Table1: Molecular information of the ligands structures obtained from PubChem. 
 
Programs  Function 
g_rms  Compares two structures by computing the root mean square deviation 
(RMSD). 
g_energy  Extracts energy components or distance restraint data from an energy 
file. 
g_hbond  Calculate hydrogen bonds formations as a function of time. 
trjconv  Extract trajectory files into PDB format. 
Table 2: List of GROMACS programs used in result collection and analysis. 
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